Evidence map›Paper›PMID 27506198›Full record

ArticleGenome medicine2016

Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer.

Kyle D Halliwill, David A Quigley, Hio Chung Kang, Reyno Del Rosario, David Ginzinger, Allan Balmain

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Pannexins in the vasculature.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Pannexin 3 channels in health and disease.Purinergic signalling · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kyle D HalliwillHelen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
David A QuigleyHelen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Hio Chung KangInvitae Corporation, 458 Brannan St, San Francisco, CA, 94107, USA.
Reyno Del RosarioHelen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
David GinzingerThermo Fisher Scientific, 5791 Van Allen Way, Carlsbad, CA, 92008, USA.
Allan BalmainHelen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Allan.Balmain@ucsf.edu.
University of California, San Francisco · USInvitae (United States) · USThermo Fisher Scientific (United States) · USUCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Identification of epithelial tumor susceptiility genesU01CA084244 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN · 1999 to 2013
$13.3M
PHARMACEUTICAL SCIENCES AND PHARMACOGENOMICST32GM007175 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, KROETZ, DEANNA L · 1985 to 2021
$7.1M
Science Leadership and IntegrationU01CA141455 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN · 2009 to 2013
$3.2M
Genetic network analysis of cancer targetsU01CA176287 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2013 to 2016
$1.2M
Genetic analysis of ras mutation specificity in skin and lung cancerR01CA184510 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN · 2015 to 2017
$1.1M
Genetic factors influencing the immune response to carcinomas in skin cancerF31CA180715 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALLIWILL, KYLE DAVID · 2013 to 2014
$72k
NCI NIH HHS F31 CA180715NCI NIH HHS R01 CA184510NCI NIH HHS U01 CA084244NCI NIH HHS U01 CA141455NCI NIH HHS U01 CA176287NIGMS NIH HHS T32 GM007175
6 · The paper itself

Abstract

backgroundBody mass index (BMI) has been implicated as a primary factor influencing cancer development. However, understanding the relationship between these two complex traits has been confounded by both environmental and genetic heterogeneity.

methodsIn order to gain insight into the genetic factors linking BMI and cancer, we performed chemical carcinogenesis on a genetically heterogeneous cohort of interspecific backcross mice ((Mus Spretus × FVB/N) F1 × FVB/N). Using this cohort, we performed quantitative trait loci (QTL) analysis to identify regions linked to BMI. We then performed an integrated analysis incorporating gene expression, sequence comparison between strains, and gene expression network analysis to identify candidate genes influencing both tumor development and BMI.

resultsAnalysis of QTL linked to tumorigenesis and BMI identified several loci associated with both phenotypes. Exploring these loci in greater detail revealed a novel relationship between the Pannexin 3 gene (Panx3) and both BMI and tumorigenesis. Panx3 is positively associated with BMI and is strongly tied to a lipid metabolism gene expression network. Pre-treatment Panx3 gene expression levels in normal skin are associated with tumor susceptibility and inhibition of Panx function strongly influences inflammation.

conclusionsThese studies have identified several genetic loci that influence both BMI and carcinogenesis and implicate Panx3 as a candidate gene that links these phenotypes through its effects on inflammation and lipid metabolism.

Indexed as

Gene Expression Regulation, NeoplasticQuantitative Trait Loci9,10-Dimethyl-1,2-benzanthraceneAnimalsBody Mass IndexCarcinogenesisCarcinogensConnexinsCrosses, GeneticFemaleGene Expression ProfilingGene Regulatory NetworksGenetic Predisposition to DiseaseHumansInflammationLipid Metabolism12-O-tetradecanoylphorbol-1,3-acetate9,10-Dimethyl-1,2-benzanthraceneCarcinogensConnexinspannexin 3 protein, mouseTetradecanoylphorbol AcetateBMICarcinogenesisLinkage analysisTumor susceptibility

Identifiers

PMID27506198
PMCPMC4977876
OpenAlexW2511719257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.